Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Glaukos Corporation stock logo
GKOS
Glaukos
$163.39
-0.3%
$171.46
$73.16
$191.62
$9.64B0.76665,841 shs1.46 million shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$152.65
$168.30
$112.50
$192.85
$3.81B0.75219,611 shs388,084 shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Glaukos Corporation stock logo
GKOS
Glaukos
0.00%-2.37%-11.99%+24.49%+95.85%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.00%-2.45%-16.51%+12.13%+15.90%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Glaukos Corporation stock logo
GKOS
Glaukos
$163.39
-0.3%
$171.46
$73.16
$191.62
$9.64B0.76665,841 shs1.46 million shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$152.65
$168.30
$112.50
$192.85
$3.81B0.75219,611 shs388,084 shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Glaukos Corporation stock logo
GKOS
Glaukos
0.00%-2.37%-11.99%+24.49%+95.85%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.00%-2.45%-16.51%+12.13%+15.90%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Glaukos Corporation stock logo
GKOS
Glaukos
2.79
Moderate Buy$178.088.99% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
2.89
Moderate Buy$192.8026.30% Upside

Current Analyst Ratings Breakdown

Latest ICUI and GKOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$193.00 ➝ $202.00
8/7/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Boost Price TargetBuy$170.00 ➝ $200.00
8/7/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Reiterated RatingStrong-Buy$200.00
8/7/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Boost Price TargetOverweight$163.00 ➝ $195.00
8/7/2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Boost Price TargetBuy$165.00 ➝ $187.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$168.00 ➝ $195.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$175.00 ➝ $190.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$175.00 ➝ $188.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Reiterated RatingOverweight$165.00 ➝ $195.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetOverweight$138.00 ➝ $178.00
7/30/2026
Glaukos Corporation stock logo
GKOS
Glaukos
Boost Price TargetBuy$150.00 ➝ $201.00
(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Glaukos Corporation stock logo
GKOS
Glaukos
$507.44M18.99N/AN/A$11.42 per share14.31
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.23B1.71$14.58 per share10.47$86.03 per share1.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Glaukos Corporation stock logo
GKOS
Glaukos
-$187.69M-$3.25N/A320.38N/A-30.68%-6.37%-4.78%11/4/2026 (Estimated)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$730K$1.18129.3619.201.931.39%7.91%4.17%11/5/2026 (Estimated)

Latest ICUI and GKOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$1.91$2.37+$0.46$0.76$533.44 million$547.88 million
7/29/2026Q2 2026
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.2105-$0.14+$0.0705-$0.31$150.93 million$185.61 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Glaukos Corporation stock logo
GKOS
Glaukos
0.10
5.04
4.46
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.56
2.43
1.21

Institutional Ownership

CompanyInstitutional Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%

Insider Ownership

CompanyInsider Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
5.90%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
1,09458.98 million55.50 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
13,00024.99 million24.47 millionOptionable

Recent News About These Companies

ICU Medical (ICUI) Receives a Buy from Piper Sandler
ICU Medical (ICUI) Stock May Be 26% Undervalued On Cash Flow
ICU Medical CFO Brian Bonnell Sells 9,307 Shares
ICU Medical CFO Sells 6,381 Shares for $1.1 Million
ICU Medical CFO Brian Bonnell Sells 9,307 Shares
Brokerages Set ICU Medical, Inc. (NASDAQ:ICUI) PT at $192.80
Raymond James Sticks to Their Buy Rating for ICU Medical (ICUI)
ICU Medical (NASDAQ:ICUI) Reports Strong Q2 CY2026

New MarketBeat Followers Over Time

Media Sentiment Over Time

Glaukos stock logo

Glaukos NYSE:GKOS

$163.39 -0.42 (-0.25%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$164.25 +0.86 (+0.52%)
As of 04:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

ICU Medical stock logo

ICU Medical NASDAQ:ICUI

$152.65 0.00 (0.00%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$152.65 +0.00 (+0.00%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.